Search research articles
Contact Us
Filters
Showing results (101-110 of 184) with videos related to
Page
of 19
Sort By:
Journal of Medicinal Chemistry
|
January 1, 1990
Alkylation of DNA by C-10 of 2,7-diaminomitosene
B S Iyengar, R T Dorr, N G Shipp, et al.
Anti-Cancer Drug Design
|
November 10, 1998
Correlation of cytotoxicity and protein-associated DNA strand breaks for 2-(arylmethylamino)-1,3-propanediols
R T Dorr, W Bellamy, J D Liddil, et al.
Toxicology
|
January 29, 1993
Administration of melanotropic peptides during gestation in the rodent
B V Dawson, C A Ford, H Holloway, et al.
Cancer Treatment Reports
|
March 1, 1987
Experimental dacarbazine antitumor activity and skin toxicity in relation to light exposure and pharmacologic antidotes
R T Dorr, D S Alberts, J Einspahr, et al.
Cancer Research
|
February 1, 1993
Characterization of experimental mitoxantrone cardiotoxicity and its partial inhibition by ICRF-187 in cultured neonatal rat heart cells
N G Shipp, R T Dorr, D S Alberts, et al.
Cancer Chemotherapy and Pharmacology
|
February 28, 2001
A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugated L-asparaginase in patients with advanced solid tumors
C W Taylor, R T Dorr, P Fanta, et al.
Biochemical Pharmacology
|
December 8, 2007
Proteasomal inhibition stabilizes topoisomerase IIalpha protein and reverses resistance to the topoisomerase II poison ethonafide (AMP-53, 6-ethoxyazonafide)
Lauren M Congdon, Alan Pourpak, Aluvia M Escalante, et al.
Breast Cancer Research and Treatment
|
January 1, 1997
Combination chemotherapy with cyclophosphamide, vincristine, adriamycin, and dexamethasone (CVAD) plus oral quinine and verapamil in patients with advanced breast cancer
C W Taylor, W S Dalton, K Mosley, et al.
International Journal of Gastrointestinal Cancer
|
October 18, 2005
Induction of apoptosis and cell cycle arrest by imexon in human pancreatic cancer cell lines
Robert T Dorr, Mary Ann Raymond, Terry H Landowski, et al.
Biopharmaceutics & Drug Disposition
|
July 1, 1994
A comparison of HPLC and bioassay methods for plasma melanotan-II (MT-II) determination: application to a pharmacokinetic study in rats
S O Ugwu, J Blanchard, L D Nguyen, et al.
Page
of 19
Search research articles
Search
Showing results (101-110 of 184) with videos related to
Sort By:
Page
of 19
Journal of Medicinal Chemistry
|
January 1, 1990
Alkylation of DNA by C-10 of 2,7-diaminomitosene
B S Iyengar, R T Dorr, N G Shipp, et al.
Anti-Cancer Drug Design
|
November 10, 1998
Correlation of cytotoxicity and protein-associated DNA strand breaks for 2-(arylmethylamino)-1,3-propanediols
R T Dorr, W Bellamy, J D Liddil, et al.
Toxicology
|
January 29, 1993
Administration of melanotropic peptides during gestation in the rodent
B V Dawson, C A Ford, H Holloway, et al.
Cancer Treatment Reports
|
March 1, 1987
Experimental dacarbazine antitumor activity and skin toxicity in relation to light exposure and pharmacologic antidotes
R T Dorr, D S Alberts, J Einspahr, et al.
Cancer Research
|
February 1, 1993
Characterization of experimental mitoxantrone cardiotoxicity and its partial inhibition by ICRF-187 in cultured neonatal rat heart cells
N G Shipp, R T Dorr, D S Alberts, et al.
Cancer Chemotherapy and Pharmacology
|
February 28, 2001
A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugated L-asparaginase in patients with advanced solid tumors
C W Taylor, R T Dorr, P Fanta, et al.
Biochemical Pharmacology
|
December 8, 2007
Proteasomal inhibition stabilizes topoisomerase IIalpha protein and reverses resistance to the topoisomerase II poison ethonafide (AMP-53, 6-ethoxyazonafide)
Lauren M Congdon, Alan Pourpak, Aluvia M Escalante, et al.
Breast Cancer Research and Treatment
|
January 1, 1997
Combination chemotherapy with cyclophosphamide, vincristine, adriamycin, and dexamethasone (CVAD) plus oral quinine and verapamil in patients with advanced breast cancer
C W Taylor, W S Dalton, K Mosley, et al.
International Journal of Gastrointestinal Cancer
|
October 18, 2005
Induction of apoptosis and cell cycle arrest by imexon in human pancreatic cancer cell lines
Robert T Dorr, Mary Ann Raymond, Terry H Landowski, et al.
Biopharmaceutics & Drug Disposition
|
July 1, 1994
A comparison of HPLC and bioassay methods for plasma melanotan-II (MT-II) determination: application to a pharmacokinetic study in rats
S O Ugwu, J Blanchard, L D Nguyen, et al.
Page
of 19